Search results - 27 results
Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance34020
Hepatitis Hepatitis E Hepatitis E virus Humans im International Cooperation IS isolation & purification journal Laboratories means methodology need Nucleic Acid Amplification Techniques ON PARTICIPANTS ...
Surveillance of sexually transmitted infections among persons living with HIV.
Reference Centers in Belgium participate in this surveillance. The reported STI include Chlamydia, gonorrhea, syphilis, Lymphogranuloma venereum, hepatitis B virus and newly acquired hepatitis C in men who ...
Establishment of a biological reference preparation for Hepatitis A Vaccine (Inactivated, Non-adsorbed)4425
hepatitis Avaccines prepared by formalin-inactivation of purified hepatitis A virus grown in cell cultures. Thus, a project waslaunched by the European Directorate for the Quality of Medicines & ...
A pyrazolotriazolopyrimidinamine inhibitor of bovine viral diarrhea virus replication that targets the viral RNA-dependent RNA polymerase.
RNA synthesis and production of infectious virus were 4.3+/-0.7microM, 12.9+/-1microM and 5.8+/-0.6microM, respectively. LZ37 proved inactive against the hepatitis C virus and the flavivirus yellow ...
Distribution of hepatitis C virus genotypes among injecting drug users in contact with treatment centers in Belgium, 2004-2005.
Keywords: Adult Belgium Female Genotype Hepacivirus Hepatitis C Humans Male Molecular Epidemiology prevalence Risk-Taking RNA, Viral Substance Abuse, Intravenous Abstract: The aim of this study was to ...
The imidazopyrrolopyridine analogue AG110 is a novel, highly selective inhibitor of pestiviruses that targets the viral RNA-dependent RNA polymerase at a hot spot for inhibition of viral replication.
microM, 5 +/- 1 microM, and 2.3 +/- 0.3 microM, respectively. AG110 proved inactive against the hepatitis C virus and a flavivirus. AG110 inhibits BVDV replication at a time point that coincides with the ...
A population-based prevalence study of hepatitis A, B and C virus using oral fluid in Flanders, Belgium.
Hepatitis A Hepatitis A Antibodies Hepatitis B Hepatitis B Surface Antigens Hepatitis C Hepatitis C Antibodies Humans Infant Infant, Newborn Male middle aged Population Surveillance prevalence Saliva ...
A novel, highly selective inhibitor of pestivirus replication that targets the viral RNA-dependent RNA polymerase.
approximately 2,000. BPIP was inactive against the hepatitis C virus subgenomic replicon and yellow fever virus but demonstrated weak activity against GB virus. Drug-resistant mutants were at least 300-fold less ...
Oral fluid as a medium for the detection of hepatitis B surface antigen.
Antigens Hepatitis B virus Humans Saliva specimen handling Abstract: Currently viral antigens and antibodies are detected by traditional serological tests. However, the introduction of oral fluid as an ...
Correlation between detection of antibodies against hepatitis C virus in oral fluid and hepatitis C virus RNA in serum.
Viral Hepacivirus Hepatitis C Hepatitis C Antibodies Humans RNA, Viral Saliva Abstract: Reported here are the results of a study designed to determine the correlation between hepatitis C virus (HCV) RNA ...